본문 바로가기
KERD
논문KCI 등재

오가피청혈플러스가 NF-κB 및 MAPKs 신호전달체계와 혈관부착인자 등에 미치는 영향

The Effect of Acanthopanax sessiliflorum Cheonghyeol Plus on NF-κB and MAPKs Signaling and Vascular Attachment Factors

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류한의학

초록

Objective: This study was performed to investigate the effect of Acanthopanax sessiliflorum Cheonghyeol plus (ASCP) on NF-κB and MAPK signaling and vascular adhesion factors associated with dyslipidemia in human umbilical vein endothelial cells (HUVECs). Methods: We measured the scavenging activity of DPPH radical and ABTS radical by ASCP in HUVECs. We measured the protein expression levels of NF-κB, IκBα, ERK, JNK, and p38 after treatment of HUVECs with TNF-α. We measured the expression levels of MCP-1, ICAM-1, and VCAM-1 mRNA and of MCP-1, ICAM-1, and VCAM-1 biomarkers after treatment of HUVECs with TNF-α. Results: The DPPH and ABTS radical scavenging activity of ASCP increased in a concentration-dependent manner. NF-κB, IκB, ERK, p38 protein expression levels decreased following ASCP treatment at all concentrations compared to untreated control HUVECs. JNK protein expression levels decreased in ASCP-treated HUVECs compared to untreated controls at concentrations of 100 µg/mL. MCP-1 mRNA expression level decreased with ASCP treatment ≥200 µg/mL compared to the control. ICAM-1 and VCAM-1 mRNA expression levels decreased at all concentrations compared to the control. MCP-1 protein expression level was reduced compared to the control at concentrations ≥200 µg/mL, ICAM-1 protein expression level was reduced compared to the control at concentrations ≥100 µg/mL, and VCAM-1 protein expression level was reduced at all concentrations. Conclusions: These results suggest that ASCP has an antioxidative and hypolipidemic effect and that ASCP could treat and prevent dyslipidemia, atherosclerosis, and cardio-cerebrovascular diseases.

Abstract

Objective: This study was performed to investigate the effect of Acanthopanax sessiliflorum Cheonghyeol plus (ASCP) on NF-κB and MAPK signaling and vascular adhesion factors associated with dyslipidemia in human umbilical vein endothelial cells (HUVECs). Methods: We measured the scavenging activity of DPPH radical and ABTS radical by ASCP in HUVECs. We measured the protein expression levels of NF-κB, IκBα, ERK, JNK, and p38 after treatment of HUVECs with TNF-α. We measured the expression levels of MCP-1, ICAM-1, and VCAM-1 mRNA and of MCP-1, ICAM-1, and VCAM-1 biomarkers after treatment of HUVECs with TNF-α. Results: The DPPH and ABTS radical scavenging activity of ASCP increased in a concentration-dependent manner. NF-κB, IκB, ERK, p38 protein expression levels decreased following ASCP treatment at all concentrations compared to untreated control HUVECs. JNK protein expression levels decreased in ASCP-treated HUVECs compared to untreated controls at concentrations of 100 µg/mL. MCP-1 mRNA expression level decreased with ASCP treatment ≥200 µg/mL compared to the control. ICAM-1 and VCAM-1 mRNA expression levels decreased at all concentrations compared to the control. MCP-1 protein expression level was reduced compared to the control at concentrations ≥200 µg/mL, ICAM-1 protein expression level was reduced compared to the control at concentrations ≥100 µg/mL, and VCAM-1 protein expression level was reduced at all concentrations. Conclusions: These results suggest that ASCP has an antioxidative and hypolipidemic effect and that ASCP could treat and prevent dyslipidemia, atherosclerosis, and cardio-cerebrovascular diseases.

참고문헌 (50)

  1. 김태현, "명일엽과 울금 추출물의 투여가 고콜레스테롤식이와 P-407로 유도한 고지혈증쥐의 혈중 지질 함량에 미치는 영향", 한국식품영양과학회지, 37(6), pp.708~713 (2008), 한국식품영양과학회
  2. Koh KK, "Vascular and metabolic effects of treatment of combined hyperlipidemia:Focus on statins and fibrates", International Journal of Cardiology, 124(2), pp.149~159 (2008)
  3. Guidelines for the management of dyslipidemia, "Korean society of lipidology and atherosclerosis", Korean society of lipidology and atherosclerosis, ~ (2015)
  4. Crandall JP, "Statin use and risk of developing diabetes : results from the diabetes prevention program", BMJ Open Daib Res Care, 5(1), pp.1~8 (2017)
  5. Jung UY, "Korean Medicine Clinicopathology", pp.545~ (1998), Younglim publisher
  6. Hasani-Ranjbar S, "The efficacy and safety of herbal medicines used in the treatment of hyperlipidemia;a systematic review", Current pharmaceutical design, 16(26), pp.2935~2947 (2010)
  7. Dinani NJ, "Hypocholesterolemic and antiathero sclerotic effect of artemisia aucheri in hypercholesterolemic rabbits", Pakistan Journal of Pharmaceutical Sciences, 23(3), pp.321~325 (2010)
  8. Dou XB, "Progress of research in treatment of hyperlipidemia by monomer or compound recipe of Chinese herbal medicine", Chinese Journal of Integrative Medicine, 14(1), pp.71~75 (2008)
  9. Singh BB, "Ayurvedic and collateral herbal treatments for hyperlipidemia : a systematic review of randomized controlled trials and quasi-experimental designs", Alternative therapies in health and medicine, 13(4), pp.22~28 (2007)
  10. 홍영기, "본초학적 접근을 통해 본 고지혈증의 최근 연구동향", 동의생리병리학회지, 24(1), pp.9~14 (2010), 한의병리학회
  11. Rouhi-Boroujeni H, "Herbs with anti-lipid effects and their interactions with statins as a chemical anti-hyperlipidemia group drugs : A systematic review", ARYA atherosclerosis, 11(4), pp.244~251 (2015)
  12. Guo J, "A new TCM formula FTZ lowers serum cholesterol by regulating HMG-CoA reductase and CYP7A1 in hyperlipidemic rats", Journal of ethnopharmacology, 135(2), pp.299~307 (2011)
  13. Liu ZL, "Chinese herbal medicines for hypercholesterolemia", The Cochrane Library, pp.1~62 (2011)
  14. Guo M, "Chinese herbal medicine on dyslipidemia : progress and perspective", Evidence-Based Complementary and Alternative Medicine, 2014, pp.163036~ (2014)
  15. Gao Q, "Rhein improves renal lesion and ameliorates dyslipidemia in db", db mice with diabetic nephropathy, 2010, pp.76(1), 27~33
  16. Du J, "Lipid-lowering effects of polydatin from Polygonum cuspidatum in hyperlipidemic hamsters", Phytomedicine, 16(6-7), pp.652~658 (2009)
  17. Chang XX, "The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet", Lipids in Health and Disease, 11, pp.86~ (2012)
  18. Kwok CY, "Cholesterol lowering and vascular protective effects of ethanolic extract of dried fruit of Crataegus pinnatifida, hawthorn(Shan Zha), in diet-induced hypercholesterolaemic rat model", Journal of Functional Foods, 5(3), pp.1326~1335 (2013)
  19. Jung ES, "A Case Report of the Beneficial Effects of Chunghyul-Plus in Dyslipidemia Patients", Korean Journal of Stroke, 17(1), pp.55~66 (2016)
  20. Congkun X, "Study on effect of Polygonum mutiflorum extract on lipid metabolism and its anti-oxidation in SD rats with hyperlipemia", China Pharmaceuticals, 18(24), pp.19~20 (2009)
  21. 김현태, "db", db mouse에서 茵蔯, 鬱金, 山査 복합추출물의 항고지혈 및 항산화 효과, 2016, pp.37(3), 467~483[DOI]
  22. 최고은, "제2형 당뇨 마우스 모델에서 청혈플러스의 항고지혈 및 항산화효과", 동의생리병리학회지, 30(3), pp.164~176 (2016), 한의병리학회[DOI]
  23. Kim TY, "Anti-dyslipidemic Effect of ACLL extract(Artemisia capillaris Thunb, Curcuma longa L, Lycium chinense, Ligustrum lucidum Aiton complex extract) on High Cholesterol Diet-induced Dyslipidemia in Mice", Daejeon university Korean medical institute, 25(1), pp.133~144 (2016)
  24. 유주영, "茵蔯, 鬱金, 枳實 추출물(ACA)이 HepG2 세포에서 나타나는 이상지질혈증 관련 인자 발현 및 항산화에 미치는 영향", 대한한방내과학회지, 38(3), pp.367~375 (2017), 대한한방내과학회
  25. 차지윤, "HepG2 cell을 이용한 한인진, 울금, 나복자 복합물(ACR)의 이상지질혈증 관련 유전자 발현 억제 및 항산화 효능 평가", 대한한의학회지, 38(3), pp.43~58 (2017), 대한한의학회[DOI]
  26. 박영숙, "고지방 식이 흰쥐에서 오가피 추출물의 항산화 효과 및 지질 개선 효과", 동아시아식생활학회지, 20(1), pp.37~45 (2010), 동아시아식생활학회
  27. Seo DH, "Effect of ChungHuyl -Plus on inflammatory factors in Human Umbilical Vein Endothelial Cells (HUVECs)", Journal of Haehwa Medicine, 27(2), pp.11~20 (2018)
  28. Kim HT, "Anti-oxidative and Anti-dyslipidemic Effects of the ChunghyulPlus(CHP) in HepG2 cells and Rats Induced Dyslipidemia by High Cholesterol diet", 박사, pp.2018
  29. Benjamin EJ, "Heart Disease and Stroke Statistics-2017 Update : A Report From the Americaan Heart Association", Circulation, 135(10), pp.e146~e603 (2017)
  30. "Korea Health Statistics 2015" (2015)[URL]
  31. "Korean Cause of Death Statistics 2019:Korean Death Rate Trend by Cause of Death" (2019)[URL]
  32. Bang HJ, "A Study of Hyperlipidemia by the theory of Traditional Korean Medicine", East-west medicine, 20(1), pp.25~36 (1995)
  33. "National Oriental Medical Department of herbology", pp.369~370 (1994), Younglim-sa
  34. 김민선, "울금(Curcuma longa L.)이 고지방․고콜레스테롤 식이 흰쥐의 항산화계 및 산화적 손상에 미치는 영향", 한국식품영양과학회지, 42(4), pp.570~576 (2013), 한국식품영양과학회
  35. 성종환, "야생 산사(Crataegus pinnatifida Bunge)가 이상지질혈증 흰쥐의 간 기능대사효소의 활성 변화에 미치는 영향", 동아시아식생활학회지, 24(2), pp.176~182 (2014), 동아시아식생활학회
  36. Go BS, "The encyclopedia of Chinese Herbal medicine", pp.216~ (1974), Shinmoonpung
  37. Kim JC, "Sim Integrated Internal Science Understood by Anatomy and Pathogenesis", pp.205~208 (2013), JungDam
  38. Swerlick RA, "Role of microvascular endothelial cells in inflammation", J Invest Dermatol, 100(1), pp.S111~ (1993)
  39. Wei CC, "Antioxidant activity, delayed aging, and reduced amyloid-βtoxicity of methanol extracts of tea seed pomace from Camellia tenuifolia", J Agric Food Chem, 62(44), pp.10701~10707 (2014)
  40. 최용민, "국내 시판되는 일부 다류 제품의 항산화 효과", 한국식품영양과학회지, 32(5), pp.723~727 (2003), 한국식품영양과학회
  41. Yun HY, "Neurobiology of nitric oxide", Crit Rev Neurobiol, 10(3-4), pp.291~316 (1996)
  42. Sheller JR, "Nuclear factor kappa B induction in airway epithelium increases lung inflammation in allergen-challenged mice", Exp Lung Res, 35(10), pp.883~895 (2009)[DOI]
  43. Schuliga M, "NF-kappaB signaling in chronic inflammatory airway disease", Biomolecules, 5(3), pp.1266~1283 (2015)[DOI]
  44. 채성원, "NF - ΚB 활성화와 면역학적 기능", 대한이비인후-두경부외과학회지, 48(3), pp.284~288 (2005), 대한이비인후과학회
  45. Song HY, "Topical transduction of superoxide dismutase mediated by HIV-1T at protein transduction domain ameliorates 12-O- tetradecanoylphorbol-13-acetate (TPA)-induced inflammation in mice", Biochem Pharmacol, 75(6), pp.1348~1357 (2008)
  46. Christopherson K, "Chemokine Regulation of Normal and Pathologic Immune Responses", Stem Cells, 19(5), pp.388~396 (2001)
  47. Rothlein R, "A form of citculating ICAM-1 in human serum", J Immunol, 147(11), pp.3788~3793 (1991)
  48. Seth R, "Circulating ICAM-1 isoforms : diagnostic prospects for inflammatory and immune disorders", Journal of The Lancet, 338, pp.83~84 (1991)
  49. Osborn L, "Direct expression cloning of vascular cell adhesion molecule 1, a cytokine-induced endothelial protein that binds to lymphocytes", Cell, 59(6), pp.1203~1211 (1989)
  50. Baran D, "Cell adhesion molecule expression in murine lupuslike nephritis induced by lipopolysaccharide", Nephron, 84(2), pp.167~176 (2000)

관련 논문AI추천

해백청혈플러스(AMCP)의 항산화 및 항염증 작용을 통한 죽상동맥경화 억제 효과김윤식, 설인찬, 유주영, 유호룡, 채인철한의병리학회 · 동의생리병리학회지2020 · 제34권 제3호금은화가 HUVEC에서 죽상동맥경화증 관련 염증인자 발현 억제에 미치는 영향김윤식, 설인찬, 양지혜, 유호룡대한한방내과학회 · 대한한방내과학회지2021 · 제42권 제1호Protective effects of Angelica keiskei extract against TNF-α-induced oxidative stress and vascular inflammation in human umbilical vein endothelial cells강은서, 김영수, 박지현, 신재영, 장선일, 조병옥, 주미현한국식품저장유통학회 · Food Science and Preservation2024 · 제31권 제4호과루인 및 과루인청혈플러스가 인간 탯줄 정맥 내피 세포(Human umbilicl vein endothelial cells, HUVECs)에서 염증인자 발현 억제에 미치는 영향김윤식, 김해융, 설인찬, 유호룡대한한방내과학회 · 대한한방내과학회지2022 · 제43권 제4호枳實과 紫花地丁 복합제(PVC)가 TNF-α로 염증 유도된 HUVEC에 미치는 항염증 효과김도연, 김현지, 전상윤대한한방내과학회 · 대한한방내과학회지2025 · 제46권 제4호혈관내피세포에서 TNF-α 자극에 의해 유도되는 혈관염증에 대한 WK-38의 억제 효과이혁, 강대길, 김은주, 윤정주, 이윤정, 이호섭, 황선미한의병리학회 · 동의생리병리학회지2009 · 제23권 제5호

이 간행물의 다른 논문 (30건)